NeoPlex™ HPV29 Detection

Real-time PCR-based test for detection of Human Papillomavirus in patient samples.

Rapid HPV detection platform compatible with common PCR instruments, delivering results within 1.5 hours and enabling efficient cervical cancer screening in clinical settings.

PCR-based human papillomavirus detection assay capable of identifying 23 HPV genotypes including 18 high-risk and 5 low-risk variants for cervical cancer screening and auxiliary diagnosis.

Fluorescence PCR-based detection kit for Human Papillomavirus (HPV) identification in clinical specimens. Enables rapid, sensitive HPV genotyping for cervical cancer screening and risk stratification in diagnostic laboratories. 510(k) cleared device with fluorescence-based detection methodology.

A fluorescence PCR-based qualitative detection kit for identifying 15 types of human papillomavirus DNA from cervical or urine samples. Includes CE certification and enables specific genotype differentiation.

Single-tube HPV detection assay that identifies 14 high-risk HPV genotypes, satisfying cervical cytology screening requirements with streamlined testing methodology.

Molecular assay for identifying 14 WHO-defined high-risk HPV types and 4 additional clinically relevant HPV types associated with cervical cancer. Enables comprehensive cervical cancer risk stratification.

A fully enclosed diagnostic kit with preloaded reagents for 6-plex detection of HPV types (HPV16, HPV18, and others) using cervical exfoliated cells and genital secretion samples. The kit employs magnetic beads extraction, purification, and qPCR method with results available within 2 hours and internal control monitoring throughout the process. It requires no freezer storage or transportation.

Rapid HPV detection platform compatible with standard PCR instruments delivering results within 1.5 hours. Provides quick turnaround for cervical screening applications.

This diagnostic kit uses real-time multiple fluorescent PCR technology combined with an Automated Fully Enclosed qPCR Instrument. It is used for in vitro qualitative detection of high-risk HPV16, HPV18, and 16 other high-risk types (HPV26, HPV31, HPV33, HPV35, HPV39, HPV45, HPV51, HPV52, HPV53, HPV56, HPV58, HPV68, HPV59, HPV66, HPV73, and HPV82) in cervical exfoliated cells or reproductive tract secretions. Test results assist in HPV auxiliary diagnosis.

A diagnostic test kit for detecting human papillomavirus (HPV) nucleic acid. This product is used for in vitro qualitative detection of HPV in clinical samples.

A comprehensive system for HPV virus detection in cervical screening programs. The collection and preservation methodology ensures accurate identification of high-risk HPV strains for cancer prevention.